Pathological characteristics of cervical adenocarcinoma in a multi-center U.S.-based study

Gynecologic Oncology

Volumn 103, Issue 2, 2006, Pages 541-546

  Wang, Sophia S ^a   Sherman, Mark E ^a   Silverberg, Steven G ^b   Carreon, Joseph D ^a   Lacey Jr , James V ^a   Zaino, Richard ^c   Kurman, Robert J ^d   Hildesheim, Allan ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenocarcinoma; Adenosquamous; Cervix; Histology; In situ; Pathology; Subtype

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CARCINOMA IN SITU; DRUG USE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; INCIDENCE; MAJOR CLINICAL STUDY; PATHOLOGY; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, ENDOMETRIOID; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; MIDDLE AGED; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 33750994632     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.03.049     Document Type: Article

References (32)

1. Sherman M.E., Wang S.S., Carreon J., and Devesa S.S. Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival. Cancer 103 (2005) 1258-1264
2. Wang S.S., Sherman M.E., Hildesheim A., Lacey Jr. J.V., and Devesa S. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer 100 (2004) 1035-1044
3. Nayar R., and Solomon D. Second edition of 'The Bethesda System for reporting cervical cytology'-Atlas, website, and Bethesda interobserver reproducibility project. Cytojournal 1 (2004) 4
4. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287 (2002) 2114-2119
5. Silverberg S.G., and Ioffe O.B. Pathology of cervical cancer. Cancer J. 9 (2003) 335-347
6. Sheets E.E. Management of adenocarcinoma in situ, micro-invasive, and early stage adenocarcinoma of the cervix. Curr. Opin. Obstet. Gynecol. 14 (2002) 53-57
7. Altekruse S.F., Lacey Jr. J.V., Brinton L.A., Gravitt P.E., Silverberg S.G., Barnes W.A., et al. Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States. Am. J. Obstet. Gynecol. 188 (2003) 657-663
8. Lacey Jr. J.V., Brinton L.A., Abbas F.M., Barnes W.A., Gravitt P.E., Greenberg M.D., et al. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol. Biomarkers Prev. 8 (1999) 1079-1085
9. Lacey Jr. J.V., Brinton L.A., Barnes W.A., Gravitt P.E., Greenberg M.D., Hadjimichael O.C., et al. Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. Gynecol. Oncol. 77 (2000) 149-154
10. Lacey Jr. J.V., Swanson C.A., Brinton L.A., Altekruse S.F., Barnes W.A., Gravitt P.E., et al. Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer 98 (2003) 814-821
11. Lacey Jr. J.V., Frisch M., Brinton L.A., Abbas F.M., Barnes W.A., Gravitt P.E., et al. Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States). Cancer Causes Control 12 (2001) 153-161
12. Hemminki K., Li X., and Vaittinen P. Time trends in the incidence of cervical and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958-1996. Eur. J. Obstet. Gynecol. Reprod. Biol. 101 (2002) 64-69
13. Alfsen G.C., Thoresen S.O., Kristensen G.B., Skovlund E., and Abeler V.M. Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioid tumors in all age groups: a population based study with review of all nonsquamous cervical carcinomas in Norway from 1966 to 1970, 1976 to 1980, and 1986 to 1990. Cancer 89 (2000) 1291-1299
14. Thoms W.W., Unger E.R., Johnson P.R., Spann C.O., Hunter S.H., Smith R., et al. Cervical cancer survival in a high risk urban population. Cancer 76 (1995) 2518-2523
15. Alfsen G.C., Kristensen G.B., Skovlund E., Pettersen E.O., and Abeler V.M. Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix. Cancer 92 (2001) 2471-2483
16. Farley J.H., Hickey K.W., Carlson J.W., Rose G.S., Kost E.R., and Harrison T.A. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma. Cancer 97 (2003) 2196-2202
17. Shingleton H.M., Bell M.C., Fremgen A., Chmiel J.S., Russell A.H., Jones W.B., et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix?. Cancer 76 (1995) 1948-1955
18. Grisaru D., Covens A., Chapman B., Shaw P., Colgan T., Murphy J., et al. Does histology influence prognosis in patients with early-stage cervical carcinoma?. Cancer 92 (2001) 2999-3004
19. Harrison T.A., Sevin B.U., Koechli O., Nguyen H.N., Averette H.E., Penalver M., et al. Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomy. Gynecol. Oncol. 50 (1993) 310-315
20. Plaxe S.C., and Saltzstein S.L. Estimation of the duration of the preclinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening. Gynecol. Oncol. 75 (1999) 55-61
21. Jones M.W., and Silverberg S.G. Cervical adenocarcinoma in young women: possible relationship to microglandular hyperplasia and use of oral contraceptives. Obstet. Gynecol. 73 (1989) 984-989
22. van Aspert-van Erp A.J., Smedts F.M., and Vooijs G.P. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the papanicolaou smear. Cancer 102 (2004) 210-217
23. Riopel M.A., Ronnett B.M., and Kurman R.J. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. Am. J. Surg. Pathol. 23 (1999) 617-635
24. Livolsi V.A., Merino M.J., and Schwartz P.E. Coexistent endocervical adenocarcinoma and mucinous adenocarcinoma of ovary: a clinicopathologic study of four cases. Int. J. Gynecol. Pathol. 1 (1983) 391-402
25. Kaminski P.F., and Norris H.J. Coexistence of ovarian neoplasms and endocervical adenocarcinoma. Obstet. Gynecol. 64 (1984) 553-556
26. Demopoulos R.I., Touger L., and Dubin N. Secondary ovarian carcinoma: a clinical and pathological evaluation. Int. J. Gynecol. Pathol. 6 (1987) 166-175
27. Lee K.R., and Flynn C.E. Early invasive adenocarcinoma of the cervix. Cancer 89 (2000) 1048-1055
28. Kaku T., Kawano Y., Hirakawa T., Koga Y., Kobayashi H., Amada S., et al. Cytological study of early cervical adenocarcinoma: special reference to the depth of invasion. Cytopathology 16 (2005) 290-294
29. Baalbergen A., Ewing-Graham P.C., Hop W.C., Struijk P., and Helmerhorst T.J. Prognostic factors in adenocarcinoma of the uterine cervix. Gynecol. Oncol. 92 (2004) 262-267
30. Pathology and Genetics of Tumours of the Breast and Female Genital Organs (2003), IARC Press, Lyon
31. Irvin W., Evans S.R., Andersen W., Jazaeri A., Taylor P., and Stoler M. The utility of HPV DNA triage in the management of cytological AGC. Am. J. Obstet. Gynecol. 193 (2005) 559-565
32. Castellsague X., Diaz M., de Sanjose S., Munoz N., Herrero R., Franceschi S., et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J. Natl. Cancer Inst. 98 (2006) 303-315